Key facts
- Aide Chemists’s last known valuation is $13.0M (Sep 2025).
- It has raised $2.6M; the latest was Seed Round ($2.0M) in Sep 2025.
- Notable investors include Microsoft for Startups, Healthtech Hub, African Union Development Agency-NEPAD, Japan International Cooperation Agency, Norrsken Evolve — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Aide Chemists
- ·The full record, as it builds
Funding rounds
No funding rounds for Aide Chemists are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aide Chemists
Developer of a pharmaceutical and digital health platform designed to improve healthcare access and outcomes in Ghana. The company offers an online pharmacy, a mobile application for medicine ordering, a health assistant for symptom triage and prescription support, and a loyalty program for regular users, enabling individuals to access affordable medicines, receive trusted health guidance, and support pharmacy growth through a franchise-based model.
- Sector
- Healthcare
- HQ
- Accra, Ghana
- Founded
- 2014
- Employees
- 42
- Website
- aidechemist.com/
- Ownership
- Privately Held (backing)
Aide Chemists doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aide Chemists shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aide Chemists in its N-PORT filings yet. We sweep new filings monthly.